Tolvaptan levels measured in healthy men
NCT ID NCT07166783
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed Phase 1 study looked at how a single 7.5mg dose of tolvaptan is processed by the body in 10 healthy men aged 18-40. Researchers measured drug levels in the blood over time to understand its absorption, distribution, and elimination. The study also checked for safety and any effects on the body.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Tolvaptan
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTH SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.